This bill caps insulin costs for people age 26 and younger who have private health insurance, effective January 1, 2026. Young people would pay no more than $35 per 30-day supply of insulin, or 25 percent of the negotiated price—whichever is lower—with no deductible required. The law applies to both employer-sponsored and individual health plans, and requires insurers to cover at least one form of each type of insulin (such as rapid-acting, long-acting, or premixed varieties) in different delivery methods like vials or pumps. These insulin cost-sharing payments would count toward annual deductibles and out-of-pocket maximums as normal. The legislation doesn't require coverage of non-preferred insulin products or affect cost-sharing for people older than 26, and regulations will be developed by the Departments of Health and Human Services, Labor, and Treasury.